December 10, 2022Affinity, analysis, analytics, bio, business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, growing, head, industry, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, medical, medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, Quality, regulation, regulatory, safety, state, studies, Study, test, Testing, therapeutics, to, trial, Zelira First Pharma vs Cannabis Clinical Trial Moves Forward Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in […]
October 27, 2020acting, adult, analysis, analytics, bioavailability, brands, business, Business Analysis, cannabinoids, cannabis, CBC, cbd, cbg, CBN, colorado, compliance, consumer, develop, development, edible, Edibles & Processing, fast, Federal, flavor, food, government, growing, gummies, industry, infused, ingredient, innovate, innovation, laboratories, labs, law, legal, legalization, legalize, legislation, license, lines, manufacture, manufacturing, marijuana, market, metabolism, Mike Hennesy, product, Product Development, productws, Quality, Quick, r&d, recreational, research, safety, Science, SKU, source, sourcing, state, supply, thc, THCV, therapeutics, use, vice president, Wana Leaders in Infused Products Manufacturing: Part 2 Cannabis infused products manufacturing is quickly becoming a massive new market. With companies producing everything from gummies to lotions, there is a […]